Eurofins Scientific (ERFp)

CBOE (Paris)Healthcare

€69.95
-€0.4 (-0.6%)
Last close

January 21, 2026 at 16:30 UTC

Interactive Chart
ERFp
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Eurofins Scientific

Name

Eurofins Scientific

CEO

Gilles G. Martin

Industry

Healthcare

Year Founded

1987

Employees

62,696

Eurofins Scientific operates a network of laboratories that deliver testing and analytical services to food, environmental, pharmaceutical, and clinical clients. The model is method first, with validated protocols and quality controls that make results comparable across sites. Samples are handled under documented custody, and privacy and data lineage are preserved through laboratory information systems. Sector teams translate regulatory requirements into workable plans so clients receive reports in accepted formats. Country labs adapt logistics and language while accreditation and governance remain centralized. In the healthcare and industrial ecosystems, the company acts as infrastructure for decisions that must rely on evidence rather than narrative.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 12 Buy, 7 Hold, 5 Sell
Buy12
Hold7
Sell5
Fundamentals & Financials
Revenue (TTM)
€5.3B
Net Income (TTM)
€309M
EPS (TTM)
€1.59
ROA (TTM)
2.92%
Current Ratio
1.26
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ2 2025
Revenue€1,806M
Cost of Sales€1,400.9M
Gross Profit€405,100K
Operating Income€377,200K
Net Income€123,300K
EPS€0.6
Technical Indicators

Eurofins Scientific's Technical Indicators Summary

ERFp is currently trading just below key short-term moving averages, with the 10-day SMA and EMA slightly above the price, signaling some near-term resistance, while medium and long-term averages remain well below, indicating a broader uptrend. Momentum indicators such as the MACD and Momentum (10) suggest modest buying strength, and the ADX reflects a strong trend presence. However, the RSI and CCI maintain moderate levels, neither overbought nor oversold, supporting a hold stance. Volume, as measured by OBV, confirms accumulation, but the price remains under the VWAP and classic pivot point, which act as resistance levels. Overall, these mixed signals contribute to a neutral technical outlook for ERFp.

Buy
12 signals
Neutral
7 signals
Sell
5 signals
Overall: Neutral29% Neutral signals
IndicatorValue
RSI (14)
65.26
Stochastic %K (14, 3, 3)
76.42
CCI (20)
54.44
WPR (14)
-34.55
Momentum (10)
1.18
MFI
71.79
MACD Level (12, 26)
3.10
Bollinger Bands
$58.12 - $76.15
ATR (14)
$1.50 (2.14%)
ADX (14)
47.93
OBV
5,987,330
VWAP
$70.60
Classic Pivot Point
$71.81
Fibonacci Pivot Point
$71.81
Exponential Moving Averages
$59.63 - $70.29(5 indicators)
Simple Moving Averages
$60.91 - $71.04(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

ERF.PA eased and currently meanders -0.114% below yesterday’s close at 70.28. Liquidity is thin; current participation stands at only 0.10× the usual flow. ERF.PA's slight decline occurs amid limited trading activity and no recent news impacting the stock.

Price Change

from €70.36 close

€-0.08

Trading Volume

Below avg (364.2K)

38K

vs S&P 500 Today

Outperforming Market

+1.98%

52-Week Position

Upper range

86%

Updated: January 21, 2026 at 12:34 UTC

Quote Summary
OpenPrevious Close
€70.74€70.36
Day Range52 Week Range
€69.76 - €71.06€45.56 - €74.32
VolumeAvg. Volume
191.2K277.3K
Market CapP/E Ratio
€12.4B30.8
Peers & Related Assets